[{"id":"7c3155ca-5d74-465f-92bf-426a11c534b7","acronym":"","url":"https://clinicaltrials.gov/study/NCT04855435","created_at":"2021-04-22T20:53:41.251Z","updated_at":"2024-07-02T16:35:32.604Z","phase":"Phase 1","brief_title":"Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours","source_id_and_acronym":"NCT04855435","lead_sponsor":"MonTa Biosciences ApS","biomarkers":" IL6 • TNFA","pipe":"","alterations":" ","tags":["IL6 • TNFA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MBS8"],"overall_status":"Recruiting","enrollment":" Enrollment 69","initiation":"Initiation: 04/12/2021","start_date":" 04/12/2021","primary_txt":" Primary completion: 04/01/2024","primary_completion_date":" 04/01/2024","study_txt":" Completion: 04/01/2024","study_completion_date":" 04/01/2024","last_update_posted":"2023-10-19"}]